PLACEBO-CONTROLLED STUDY OF MESULERGINE IN PARKINSONS-DISEASE

被引：11

作者：

JANKOVIC, J ^{[1
]}

ORMAN, J ^{[1
]}

JANSSON, B ^{[1
]}

机构：

[1] TEXAS MED CTR,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030

来源：

NEUROLOGY | 1985年 / 35卷 / 02期

关键词：

D O I：

10.1212/WNL.35.2.161

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：161 / 165

页数：5

相关论文

共 30 条

[1] [Anonymous], 1982, MOVEMENT DISORD
[2] THERAPEUTIC EXPERIENCE WITH THE NEW DOPAMINE AGONIST CU-32-085 IN ADVANCED PARKINSONS-DISEASE
BIESEMEYER, H
LUDIN, HP
RINGWALD, E
[J]. JOURNAL OF NEUROLOGY, 1983, 230 (01) : 19 - 23
[3] A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONS-DISEASE
CANTER, GJ
DELATORRE, R
MIER, M
[J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1961, 133 (02) : 143 - 147
[4] CREESE I, 1982, J CLIN PSYCHOPHARM, V2, P239
[5] BIPHASIC INFLUENCE OF A 8-ALPHA-AMINO ERGOLINE, CU 32-085, ON STRIATAL DOPAMINE SYNTHESIS AND TURNOVER INVIVO IN THE RAT
ENZ, A
[J]. LIFE SCIENCES, 1981, 29 (21) : 2227 - 2234
[6] FLUCKIGER E, 1979, EXPERIENTIA, V35, P1677, DOI 10.1007/BF01953267
[7] BEHAVIORAL CORRELATIONS OF DOPAMINE RECEPTOR ACTIVATION
GERSHANIK, O
HEIKKILA, RE
DUVOISIN, RC
[J]. NEUROLOGY, 1983, 33 (11) : 1489 - 1492
[8] PARKINSONISM - ONSET PROGRESSION AND MORTALITY
HOEHN, MM
YAHR, MD
[J]. NEUROLOGY, 1967, 17 (05) : 427 - &
[9] HOEHN MM, 1983, ANN NEUROL, V14, P111
[10] ILSON J, 1983, LISURIDE OTHER DOPAM, P443